Negative regulation of DSS-induced experimental colitis by PILRa

International Immunology

Volumn 27, Issue 6, 2015, Pages 307-314

  Kishida, Kazuki ^a,b   Kohyama, Masako ^a,b   Kurashima, Yosuke ^c,d   Kogure, Yuta ^c,d   Wang, Jing ^a,b,f   Hirayasu, Kouyuki ^a,b   Suenaga, Tadahiro ^a,b   Kiyono, Hiroshi ^c   Kunisawa, Jun ^c,d   Arase, Hisashi ^a,b,e  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colitis; Immune regulation; Inflammation; Inhibitory receptor

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR2; DEXTRAN SULFATE; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; INTERLEUKIN 6; PAIRED IMMUNOGLOBULIN LIKE TYPE 2 RECEPTOR ALPHA; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; PILRALPHA PROTEIN, MOUSE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOODY DIARRHEA; CELL COUNT; CELL POPULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DEXTRAN SULFATE INDUCED EXPERIMENTAL COLITIS; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; IMMUNOREGULATION; LAMINA PROPRIA; MACROPHAGE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; WEIGHT REDUCTION; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; CHEMICALLY INDUCED; COLITIS; COLON; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; COLITIS; COLON; DEXTRAN SULFATE; DISEASE PROGRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-8B;

EID: 84939492857     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxv004     Document Type: Article

References (48)

1. Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L. and Arase, H. 2004. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulinlike type 2 receptor. J. Exp. Med. 199:525.
2. Fournier, N., Chalus, L., Durand, I. et al. 2000. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J. Immunol. 165:1197.
3. Mousseau, D. D., Banville, D., L'Abbé, D., Bouchard, P. and Shen, S. H. 2000. PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J. Biol. Chem. 275:4467.
4. Wilson, M. D., Cheung, J., Martindale, D. W., Scherer, S. W. and Koop, B. F. 2006. Comparative analysis of the paired immunoglobulin- like receptor (PILR) locus in six mammalian genomes: duplication, conversion, and the birth of new genes. Physiol. Genomics 27:201.
5. Arii, J., Wang, J., Morimoto, T. et al. 2010. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis. J. Virol. 84:10773.
6. Wang, J., Fan, Q., Satoh, T. et al. 2009. Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB. J. Virol. 83:13042.
7. Satoh, T., Arii, J., Suenaga, T. et al. 2008. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132:935.
8. Kogure, A., Shiratori, I., Wang, J., Lanier, L. L. and Arase, H. 2011. PANP is a novel O-glycosylated PILRα ligand expressed in neural tissues. Biochem. Biophys. Res. Commun. 405:428.
9. Sun, Y., Senger, K., Baginski, T. K. et al. 2012. Evolutionarily conserved paired immunoglobulin-like receptor α (PILRα) domain mediates its interaction with diverse sialylated ligands. J. Biol. Chem. 287:15837.
10. Wang, J., Shiratori, I., Satoh, T., Lanier, L. L. and Arase, H. 2008. An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR). J. Immunol. 180:1686.
11. Kuroki, K., Wang, J., Ose, T. et al. 2014. Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRα. Proc. Natl Acad. Sci. USA 111:8877.
12. Wang, J., Shiratori, I., Uehori, J., Ikawa, M. and Arase, H. 2013. Neutrophil infiltration during inflammation is regulated by PILRα via modulation of integrin activation. Nat. Immunol. 14:34.
13. Sun, Y., Caplazi, P., Zhang, J. et al. 2014. PILRα negatively regulates mouse inflammatory arthritis. J. Immunol. 193:860.
14. Mantovani, A., Cassatella, M. A., Costantini, C. and Jaillon, S. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:519.
15. Borregaard, N. 2010. Neutrophils, from marrow to microbes. Immunity 33:657.
16. Naito, Y., Takagi, T. and Yoshikawa, T. 2007. Neutrophil-dependent oxidative stress in ulcerative colitis. J. Clin. Biochem. Nutr. 41:18.
17. White, J. R., Lee, J. M., Young, P. R. et al. 1998. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J. Biol. Chem. 273:10095.
18. Foell, D., Kucharzik, T., Kraft, M. et al. 2003. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52:847.
19. Carlson, M., Raab, Y., Sevéus, L., Xu, S., Hällgren, R. and Venge, P. 2002. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 50:501.
20. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694.
21. Kitajima, S., Takuma, S. and Morimoto, M. 1999. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp. Anim. 48:137.
22. Perše, M. and Cerar, A. 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012:718617.
23. Hall, L. J., Faivre, E., Quinlan, A., Shanahan, F., Nally, K. and Melgar, S. 2011. Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig. Dis. Sci. 56:79.
24. Weber, D. A., Sumagin, R., McCall, I. C. et al. 2014. Neutrophilderived JAML inhibits repair of intestinal epithelial injury during acute inflammation. Mucosal Immunol. 7:1221.
25. Bento, A. F., Leite, D. F., Claudino, R. F., Hara, D. B., Leal, P. C. and Calixto, J. B. 2008. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J. Leukoc. Biol. 84:1213.
26. Morohoshi, Y., Matsuoka, K., Chinen, H. et al. 2006. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J. Gastroenterol. 41:318.
27. Kurashima, Y. and Kiyono, H. 2014. New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development. Exp. Mol. Med. 46:e83.
28. Kurashima, Y., Amiya, T., Nochi, T. et al. 2012. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat. Commun. 3:1034.
29. De Filippo, K., Dudeck, A., Hasenberg, M. et al. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121:4930.
30. Hamilton, M. J., Sinnamon, M. J., Lyng, G. D. et al. 2011. Essential role for mast cell tryptase in acute experimental colitis. Proc. Natl Acad. Sci. USA 108:290.
31. Buanne, P., Di Carlo, E., Caputi, L. et al. 2007. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J. Leukoc. Biol. 82:1239.
32. Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D. and Fine, J. S. 2009. CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol. Ther. 121:55.
33. Atarashi, K., Nishimura, J., Shima, T. et al. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808.
34. Mowat, A. M. and Bain, C. C. 2011. Mucosal macrophages in intestinal homeostasis and inflammation. J. Innate Immun. 3:550.
35. Denning, T. L., Norris, B. A., Medina-Contreras, O. et al. 2011. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 187:733.
36. Fournier, B. M. and Parkos, C. A. 2012. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5:354.
37. Nagarkar, D. R., Wang, Q., Shim, J. et al. 2009. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J. Immunol. 183:6698.
38. Jang, J. E., Hod, E. A., Spitalnik, S. L. and Frenette, P. S. 2011. CXCL1 and its receptor, CXCR2, mediate murine sickle cell vasoocclusion during hemolytic transfusion reactions. J. Clin. Invest. 121:1397.
39. Jacobs, J. P., Ortiz-Lopez, A., Campbell, J. J., Gerard, C. J., Mathis, D. and Benoist, C. 2010. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 62:1921.
40. Yanning, Wu., Shuo, Wang., Shukkur M.F., et al. 2012. A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases. J. Biol. Chem. 287:5744
41. Kühl, A. A., Kakirman, H., Janotta, M. et al. 2007. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 133:1882.
42. Kumar, V. and Sharma, A. 2010. Neutrophils: Cinderella of innate immune system. Int. Immunopharmacol. 10:1325.
43. Shepherd, V. L. and Hoidal, J. R. 1990. Clearance of neutrophilderived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell Mol. Biol. 2:335.
44. Munitz, A., Cole, E. T., Beichler, A. et al. 2010. Paired immunoglobulin- like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. Gastroenterology 139:530.
45. Takai, T. 2005. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 115:433.
46. Ujike, A., Takeda, K., Nakamura, A., Ebihara, S., Akiyama, K. and Takai, T. 2002. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat. Immunol. 3:542.
47. Endo, S., Sakamoto, Y., Kobayashi, E., Nakamura, A. and Takai, T. 2008. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. Proc. Natl Acad. Sci. USA 105:14515.
48. Ma, G., Pan, P. Y., Eisenstein, S. et al. 2011. Paired immunoglobinlike receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34:385.